Skip to main content
Clinical Trials/ACTRN12609000596202
ACTRN12609000596202
Recruiting
Phase 3

A prospective randomised trial to study the effect of intravenous iron infusion versus oral iron therapy on pre-operative haemoglobin levels and peri-operative blood transfusion requirement in patients with pre-operative anaemia

Clifford Craig Medical Research Trust0 sites120 target enrollmentJuly 20, 2009

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Pre-operative anaemia in elective surgery patients e.g. in orthoplasty (hip- and Knee replacement) and gynaecological elective surgery etc...
Sponsor
Clifford Craig Medical Research Trust
Enrollment
120
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 20, 2009
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Clifford Craig Medical Research Trust

Eligibility Criteria

Inclusion Criteria

  • The inclusion criteria is a preoperative Hb above 90 g/L but less than 140 g/L for males and 120 g/L for females as compared to the reference normal range and measured at the Launceston General Hospital (LGH) Laboratory.

Exclusion Criteria

  • Patients with any specific causes for anaemia apart from haematincs deficiency, or a haemoglobin below 90 g/L will be excluded from the study and will be investigated throughly and offered the appropriate treatment according the cause of anaemia. Any hypersensitivity reactions to any of the drugs involved in this study are considered as exclusion criteria. 1\. Presence of a specific cause for anaemia apart from haematinic deficiency 2\. Vitamin B12/folate deficiency (Megaloblastic anaemia) 3\. Myelodysplasia 4 4\. Aplastic Anaemia 5\. Haemolysis 6\. Bone marrow diseases 7\. Malignancy 8\. Renal insufficiency 9\. Other disorders as documented by clinician. A. Documented iron overload status. B.Patients with polycythaemia (according World Health Organization criteria) will be excluded from the normal control group.

Outcomes

Primary Outcomes

Not specified

Similar Trials